Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo’s next-gen obesity drug misses expectations in closely watched trial
BioPharma Dive
Fri, 12/20/24 - 11:34 am
Tags:
Novo Nordisk, CagriSema, clinical trials, weight loss
Novo Nordisk taps Photys for $186M cardiometabolic collab
Fierce Biotech
Wed, 12/18/24 - 11:21 am
Tags:
Novo Nordisk, Photys, MASH, chronic kidney disease
A new GLP-1 opportunity for pharma: Supporting patients’ emotional barriers to weight loss
Pharmaphorum
Wed, 12/18/24 - 11:14 am
Tags:
patients, GLP-1 agonists, obesity, weight loss, Novo Nordisk, Eli Lilly
Novo Nordisk blueprints $1.2B rare disease production plant in Denmark, where it plans to hire on 400 new staffers
Fierce Pharma
Mon, 12/16/24 - 11:44 am
Tags:
Novo Nordisk, Denmark, drug manufacturing
Novo Nordisk's Ozempic reportedly linked to vision loss in new study
Yahoo Finance
Mon, 12/16/24 - 11:39 am
Tags:
Novo Nordisk, Ozempic, vision loss
UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy
Yahoo/Reuters
Fri, 12/13/24 - 11:43 am
Tags:
Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, UK, obesity
Novo Nordisk slashes prices of additional insulin products but not until 2026
Fierce Pharma
Sun, 12/8/24 - 09:42 pm
Tags:
Novo Nordisk, insulin, diabetes, drug pricing
Novo Nordisk to cut US list prices of two insulin products by more than 70%
MSN/Reuters
Thu, 12/5/24 - 04:14 pm
Tags:
Novo Nordisk, drug pricing, insulin, Fiasp, Tresiba, diabetes
Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark
Fierce Pharma
Thu, 12/5/24 - 11:17 am
Tags:
Novo Nordisk, Denmark, drug manufacturing
Antag, a startup backed by Versant and Novo, joins hunt for obesity drug alternatives
BioPharma Dive
Wed, 12/4/24 - 11:15 pm
Tags:
Antag Therapeutics, Versant, Novo Nordisk, obesity
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
Yahoo/Reuters
Wed, 12/4/24 - 11:08 am
Tags:
Novavax, Novo Nordisk, czech republic, drug manufacturing
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial
BioPharma Dive
Wed, 12/4/24 - 11:02 am
Tags:
Eli Lilly, Zepbound, Novo Nordisk, Wegovy, clinical trials, weight loss, obesity
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Pharma Live
Tue, 12/3/24 - 11:36 am
Tags:
Novo Nordisk, India, Wegovy, Eli Lilly, Zepbound
Four oral GLP-1R products in Phase III trials as race intensifies
Clinical Trials Arena
Tue, 12/3/24 - 11:17 am
Tags:
Novo Nordisk, Eli Lilly, Jiangsu Hengrui, GLP-1R, GLP-1 agonists, clinical trials
Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack
MSN
Wed, 11/27/24 - 09:57 pm
Tags:
Novo Nordisk, Wegovy, Canada, Health Canada, obesity
Biden proposes Medicare and Medicaid cover weight loss drugs
Axios
Tue, 11/26/24 - 09:51 am
Tags:
Joe Biden, Medicare, Medicaid, obesity, Novo Nordisk, Eli Lilly, Zepbound, Wegovy, Ozempic
Pfizer led industrywide sales surge in Q3 after several quarters of dominance by Eli Lilly, Novo Nordisk
Fierce Pharma
Mon, 11/25/24 - 11:43 am
Tags:
Pfizer, earnings, Eli Lilly, Novo Nordisk
Novo, Viking heat up MASH space with promising data at AASLD24
BioSpace
Wed, 11/20/24 - 11:40 am
Tags:
Novo Nordisk, Viking Therapeutics, MASH, AASLD, GLP-1 agonists, semaglutide, VK2809
Drugmakers and pharmacists battle over who gets to make obesity drugs
NPR
Wed, 11/20/24 - 11:21 am
Tags:
Novo Nordisk, Eli Lilly, obesity, weight loss, GLP-1 agonists, compounded drugs
Novo’s Wegovy Launched in China at a Fraction of US Price
BioSpace
Mon, 11/18/24 - 11:28 am
Tags:
Novo Nordisk, Wegovy, Cina, weight loss, GLP-1 agonists

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.